Guselkumab for Hidradenitis Suppurativa, a Mode of Action Study.

Condition:   Hidradenitis Suppurativa Intervention:   Biological: Guselkumab Sponsors:   Barbara Horváth, Principal Investigator;   Janssen-Cilag Ltd. Not yet recruiting

Source: ClinicalTrials.gov - August 19, 2019 Category: Research Source Type: clinical trials